David A. Siegel Inspire Medical Systems, Inc. Transaction History

Two Sigma Advisers, LP

$47 Billion
Q3 2025

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Inspire Medical Systems, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 20,000 shares of INSP stock, worth $1.73 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,000

Holding current value

$1.73 Million

% of portfolio

0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$74.2 - $139.25 $1.48 Million - $2.79 Million	20,000 New	20,000 $1.48 Million
Q1 2025 May 15, 2025	BUY	$157.24 - $215.42 $1.2 Million - $1.64 Million	7,600 New	7,600 $1.21 Million
Q3 2024 Nov 14, 2024	BUY	$125.79 - $216.71 $201,264 - $346,736	1,600 New	1,600 $337,000
Q2 2023 Aug 14, 2023	BUY	$226.52 - $324.64 $5.35 Million - $7.66 Million	23,600 Added 983.33%	26,000 $8.44 Million
Q1 2023 May 15, 2023	BUY	$229.06 - $278.01 $549,744 - $667,224	2,400 New	2,400 $561,000
Q4 2020 Feb 16, 2021	SELL	$119.35 - $200.46 $226,765 - $380,874	-1,900 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$87.5 - $130.91 $420,000 - $628,368	-4,800 Reduced 71.64%	1,900 $245,000
Q2 2020 Aug 14, 2020	BUY	$49.5 - $97.93 $128,700 - $254,618	2,600 Added 63.41%	6,700 $583,000
Q1 2020 May 15, 2020	BUY	$41.62 - $89.92 $170,642 - $368,672	4,100 New	4,100 $247,000
Q3 2019 Nov 14, 2019	SELL	$61.02 - $70.19 $311,202 - $357,969	-5,100 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$47.07 - $60.71 $47,070 - $60,710	-1,000 Reduced 16.39%	5,100 $309,000
Q1 2019 May 15, 2019	BUY	$39.48 - $62.0 $240,827 - $378,200	6,100 New	6,100 $346,000

Others Institutions Holding INSP

# of Institutions

373

Shares Held

29M

Call Options Held

101K

Put Options Held

246K

View Full List

About Inspire Medical Systems, Inc.

Ticker INSP
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 28,788,600
Market Cap $2.49B
Description
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for m...

More about INSP

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account